HealthcareServices

Insomnia Market Report 2026: Strategic Insights and Revenue Outlook

February 25, 2026February 26, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the insomnia market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Insomnia Market show for the 2026–2030 period?

The insomnia market has experienced robust expansion in recent years. It is projected to grow from $5.22 billion in 2025 to $5.52 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.7%. This historical growth can be attributed to a rising prevalence of sleep disorders, increased stress and lifestyle changes, widespread use of benzodiazepines and sedatives, growing diagnosis rates of insomnia, and the expansion of sleep clinics and specialists.

The insomnia market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $7.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. Several factors contribute to this growth during the projected timeframe, including the wider acceptance of digital therapeutics, an escalating need for safer and more enduring insomnia remedies, an expanding elderly demographic, heightened awareness surrounding mental health issues, and broader availability through online and retail pharmacies. Key trends expected within this forecast period encompass the increasing embrace of non-drug-based insomnia therapies, a greater reliance on cognitive behavioral therapy for insomnia, a developing preference for tailored sleep management solutions, the broadening application of combined therapeutic strategies, and a heightened understanding of chronic insomnia as a legitimate medical ailment.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12120&type=smp

What Drivers Are Shaping The Development Of The Insomnia Market?

The rising occurrence of chronic illnesses is anticipated to fuel the expansion of the insomnia market in the future. A chronic disease is defined as an ailment persisting for at least three months, with the potential to worsen over time. People affected by chronic conditions like cardiovascular disorders, diabetes, and ongoing pain frequently encounter insomnia or other sleep problems as an associated condition. This growing incidence fuels a need for effective treatments and management approaches for insomnia, thereby stimulating the market for solutions addressing sleep disorders. For example, in April 2025, data from the Centers for Disease Control and Prevention, a US-based federal public health agency, indicated that in 2023, 76.4% of US adults, approximately 194 million individuals, reported having at least one chronic condition. The prevalence was observed to be 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the rising prevalence of chronic diseases is a significant factor in the expansion of the insomnia market.

What Segment Types Are Examined In The Insomnia Market?

The insomnia market covered in this report is segmented –

1) By Therapy Type: Non-Pharmacological Therapy, Pharmacological Therapy

2) By Drug Class: Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Non-Pharmacological Therapy: Cognitive Behavioral Therapy For Insomnia (CBT-I), Sleep Hygiene Education, Relaxation Techniques, Stimulus Control Therapy, Sleep Restriction Therapy

2) By Pharmacological Therapy: Prescription Medications, Over-The-Counter, Herbal Supplements

Which Trends Are Shaping Activity Within The Insomnia Market?

Major companies in the insomnia market are innovating by developing new products, such as zaleplon-based insomnia drugs, to secure a competitive edge. Zaleplon is classified as a non-benzodiazepine sedative-hypnotic medication, prescribed for the short-term management of insomnia. For instance, in April 2023, Bukwang Pharm Co Ltd., a pharmaceutical company based in South Korea, introduced Zaledeep Cap., which marks the first insomnia treatment in South Korea to utilize zaleplon as its primary ingredient. This non-benzodiazepine drug, zaleplon, holds FDA approval for treating insomnia and is distinguished by its rapid onset of action, short half-life, and minimal disruption to daily activities. Given the increasing prevalence of insomnia in modern society, the release of Zaledeep Cap. is projected to offer a novel and effective treatment pathway, with the goal of enhancing sleep quality and overall well-being for individuals experiencing insomnia.

Who Are The Primary Competitors In The Global Insomnia Market?

Major companies operating in the insomnia market are Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

Which Regions Are Poised For Strategic Growth In The Insomnia Market?

North America was the largest region in the insomnia market in 2025. The regions covered in the insomnia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Insomnia Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12120&type=smp

Browse Through More Reports Similar to the Global Insomnia Market 2026, By The Business Research Company

Sleep Monitoring Apps Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-monitoring-apps-global-market-report

Sleeping Aids Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

Dental Sleep Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-sleep-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795